These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14743020)

  • 1. Pharmacologic considerations for cataract surgery.
    Tipperman R
    Curr Opin Ophthalmol; 2004 Feb; 15(1):51-5. PubMed ID: 14743020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH; Stark WJ; O'Brien TP; Dick JD
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.
    Deramo VA; Lai JC; Fastenberg DM; Udell IJ
    Am J Ophthalmol; 2006 Nov; 142(5):721-5. PubMed ID: 16989762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
    Moshirfar M; Feiz V; Vitale AT; Wegelin JA; Basavanthappa S; Wolsey DH
    Ophthalmology; 2007 Apr; 114(4):686-91. PubMed ID: 17184840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.
    Jensen MK; Fiscella RG
    Am J Health Syst Pharm; 2006 Sep; 63(17):1637-40. PubMed ID: 16914634
    [No Abstract]   [Full Text] [Related]  

  • 6. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations.
    Fiscella RG; Lewis CC; Jensen MK
    Am J Health Syst Pharm; 2007 Oct; 64(19):2069-73. PubMed ID: 17893419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
    Shorstein NH; Winthrop KL; Herrinton LJ
    J Cataract Refract Surg; 2013 Jan; 39(1):8-14. PubMed ID: 23036356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients.
    Espiritu CR; Caparas VL; Bolinao JG
    J Cataract Refract Surg; 2007 Jan; 33(1):63-8. PubMed ID: 17189795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.
    Moshirfar M; Chew J; Werner L; Meyer JJ; Hunter B; Stevens S; Jensen M; Kleinmann G; Mamalis N
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1455-61. PubMed ID: 18642018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.
    Kim DH; Stark WJ; O'Brien TP
    Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
    Moshirfar M; Marx DP; Kumar R
    Cornea; 2005 Oct; 24(7):833-6. PubMed ID: 16160500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.
    O'Brien TP; Arshinoff SA; Mah FS
    J Cataract Refract Surg; 2007 Oct; 33(10):1790-800. PubMed ID: 17889778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of prophylactic intracameral moxifloxacin use in cataract surgery.
    Ekinci Koktekir B; Aslan BS
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):278-82. PubMed ID: 22304496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.
    Arbisser LB
    J Cataract Refract Surg; 2008 Jul; 34(7):1114-20. PubMed ID: 18571078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Laws TR; Thirlwall RE; MacMillan AP; Brooks TJ; Simpson AJ
    Int J Antimicrob Agents; 2009 Nov; 34(5):471-3. PubMed ID: 19682862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.
    Burka JM; Bower KS; Vanroekel RC; Stutzman RD; Kuzmowych CP; Howard RS
    Am J Ophthalmol; 2005 Jul; 140(1):83-7. PubMed ID: 15953577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of besifloxacin ophthalmic suspension 0.6% in cataract surgery patients.
    Parekh JG; Newsom TH; Nielsen S
    J Cataract Refract Surg; 2012 Oct; 38(10):1864-7. PubMed ID: 22999608
    [No Abstract]   [Full Text] [Related]  

  • 19. Transzonular Triamcinolone-Moxifloxacin Versus Topical Drops for the Prophylaxis of Postoperative Inflammation After Cataract Surgery.
    Singhal R; Luo A; O'Rourke T; Scott IU; Pantanelli SM
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):565-570. PubMed ID: 31613699
    [No Abstract]   [Full Text] [Related]  

  • 20. [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
    Hoepelman I
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2115-21. PubMed ID: 15553354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.